NASDAQ: APVO
Aptevo Therapeutics Inc Stock Ownership - Who owns Aptevo Therapeutics?

Insider buying vs selling

Have Aptevo Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when APVO insiders and whales buy or sell their stock.

APVO Shareholders

What type of owners hold Aptevo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri745.29%3,021,899$9.07MInsider
Scott C. Stromatt53.32%216,183$648.55kInsider
Jane A. Gross27.03%109,583$328.75kInsider
Shawnte Mitchell19.86%80,527$241.58kInsider
Randy Joe Maddux18.50%75,000$225.00kInsider
Michael Adelman17.37%70,426$211.28kInsider
Geode Capital Management LLC2.60%10,526$31.58kInstitution
Tower Research Capital LLC Trc0.80%3,255$9.77kInstitution
Clear Street LLC0.69%2,800$8.40kInstitution
Bank Of America Corp0.57%2,318$6.95kInstitution

1 of 3

APVO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APVO0.55%99.45%
OGEN0.68%99.32%Net SellingNet Selling
SLRX0.55%99.45%
TNFA1.39%51.39%
REVB0.10%99.90%Net Buying

Aptevo Therapeutics Stock Ownership FAQ

Who owns Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ: APVO) is owned by 4.84% institutional shareholders, 881.69% Aptevo Therapeutics insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Aptevo Therapeutics shareholder, owning 3.02M shares representing 745.29% of the company. Fuad Elhibri's Aptevo Therapeutics shares are currently valued at $8.91M.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.